Deep, qualified following-era sequencing has exposed that subclonal mutations (i.e., Individuals existing in only a fraction of tumor cells) might be detected for all driver genes and they are associated with swift ailment progression and weak result.11–13 This is especially applicable for TP53Sebagai jaminan yang kami tawarkan misalnya ada siste